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Abstract
Acute, inflammatory conditions associated with dysregulated complement activation
are characterized by significant increases in blood concentration of reactive oxygen
species (ROS) and ATP. The mechanisms by which these molecules arise are not fully
understood. In this study, using luminometric- and fluorescence-based methods, we show
that ligation of glycophorin A (GPA) on human red blood cells (RBCs) results in a 2.1-fold,
NADPH-oxidase-dependent increase in intracellular ROS that, in turn, trigger multiple
downstream cascades leading to caspase-3 activation, ATP release, and increased band
3 phosphorylation. Functionally, using 2D microchannels to assess membrane deformabil-
ity, GPS-ligated RBCs travel 33% slower than control RBCs, and lipid mobility was hindered
by 10% using fluorescence recovery after photobleaching (FRAP). These outcomes were
preventable by pretreating RBCs with cell-permeable ROS scavenger glutathione mono-
ethyl ester (GSH-ME). Our results obtained in vitro using anti-GPA antibodies were vali-
dated using complement-altered RBCs isolated from control and septic patients. Our
results suggest that during inflammatory conditions, circulating RBCs significantly contrib-
ute to capillary flow dysfunctions, and constitute an important but overlooked source of intra-
vascular ROS and ATP, both critical mediators responsible for endothelial cell activation,
microcirculation impairment, platelet activation, as well as long-term dysregulated adaptive
and innate immune responses.
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Introduction
In humans, during normal conditions, low concentrations of complement-opsonized circulating
inflammatory particles are bound to red blood cells (RBCs) via complement receptor 1 (CR1)
and delivered to resident sinusoidal macrophages in the liver and spleen, a process known as
immune-adherence clearance [1,2]. During periods of excessive complement activation, nascent
C3b and C4b fragments bind irreversibly through thioester bonds to hydroxyl groups of heavily
glycosylated glycophorin A (GPA) on circulating RBCs [3]. Our results using RBCs isolated from
SLE [4] and trauma patients demonstrate that binding nascent complement fragments C3b and
C4b to human RBC plasma membranes has significant negative effects on RBC function, namely
β-spectrin phosphorylation and decreased membrane deformability [5,6]. In vitro engagement of
GPA by complement fragments significantly impacts membrane protein functionality, leading to
decreased diffusion of key complement regulatory proteins, namely CD35, CD55 and CD59, and
promoting the formation of new protein complexes between GPA/band 3/ankyrin and spectrin
that directly impacts membrane deformability [7]. Furthermore, GPA ligation has been associ-
ated with increasing RBCmembrane rigidity, which impairs RBC flow through the microcircula-
tion [8]. The mechanical and biochemical consequences on human RBCs following GPA
engagement either by naturally occurring auto-antibodies [9] or complement fragments [5–7]
may represent an initial signal triggering a cascade of events culminating with the premature
removal of altered RBCs from circulation. Acute inflammatory conditions associated with com-
plement activation have been correlated with reductions in capillary flow and corresponding
decreases in microcirculatory perfusion [10,11].
Reactive oxygen species (ROS) are constantly produced by RBCs through oxygen transport,
generating high levels of oxidative stress that significantly reduces its lifespan [12]. Mature
RBCs lacking biosynthesis machinery rely exclusively on enzymes produced earlier in develop-
ment to maintain ROS scavenger systems. Genetic or acquired conditions associated with
decreased ROS scavenging capabilities can cause extensive membrane damage leading to
reduced RBC half-life and intravascular hemolysis [13]. Acute and chronic inflammatory con-
ditions associated with complement activation promote a sustained increase in total blood
ROS content that parallels disease severity. Whether RBCs could be a source of intravascular
ROS during acute and chronic inflammatory conditions is currently unknown.
In the past decade, an intravascular purinergic overload critical in initiating, maintaining,
and propagating host maladaptive inflammatory responses has begun to be revealed in diseases
associated with excessive complement activation [14–17]. A detrimental effect of ATP and
adenosine receptors (P2Y2 and A3) in the host’s response to injury using a murine model of
septic shock was also reported. Mice lacking either P2Y2 or A3 receptors showed reduced
organ damage and mortality following septic shock [18]. These data strongly argue that ATP
and its by-products, acting on their cognate receptors, are essential for the disproportionate
PMN and T cell inflammatory host responses that characterize acute and chronic inflamma-
tory conditions such as sepsis. The source(s) of increased circulating ATP is currently not
known, and the molecular mechanisms regulating ATP release remain poorly defined.
Our results show that GPA ligation induces a NADPH oxidase-dependent increase in the
intracellular concentration of ROS, which, in turn, trigger multiple downstream cascades lead-
ing to caspase-3 activation, increased band 3 phosphorylation, and significant RBC ATP
release. Functionally, excessive ROS production has a direct, detrimental effect on RBC mem-
brane deformability and lipid mobility, outcomes that are preventable or partially reversed by
incubating RBCs with cell permeable ROS scavengers. Our results obtained in vitro using anti-
GPA antibodies were partially validated using RBCs isolated from septic patients, suggesting
that during inflammatory conditions, circulating RBCs could constitute an important but
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overlooked source of intravascular ROS and ATP, both critical mediators responsible for endo-
thelial cell activation, and microcirculation impairment.
Experimental Procedures
Antibodies
Antibodies were obtained as follows—LEAF purified mouse IgG1 (401404); LEAF purified
mouse IgM (401604, Biolegend, San Diego, CA, USA); mouse anti-phosphotyrosine mAb (Life
Technologies, Carlsbad, CA, USA); mouse monoclonal anti-beta-actin Ab (A2228), mouse
monoclonal anti-glycophorin A IgG (clone R10, Lot B0607, sc-53905); mouse monoclonal
anti-GPA IgM (clone E4, G7900, Sigma-Aldrich, St Louis, MO, USA); anti-CR1 mAb 1F11
(gift of Henry Marsh, Celldex Therapeutics, Needham, MA, USA); mouse monoclonal anti-
CFTR (CF3) (ab2784, both Abcam, Cambridge, MA, USA); AffiniPure goat anti-mouse IgG
(115-005-003); ChromPure rabbit IgG (011-000-003); ChromPure mouse IgG (015-000-003,
Jackson ImmunoResearch, West Grove, PA, USA); HRP conjugated goat anti-mouse antibody
(Millipore, Billerica, MA, USA); mouse monoclonal anti-human C3d (A207), mouse monoclo-
nal anti-human C4d (A213, Quidel, San Diego, CA, USA).
Reagents were obtained as follows
2–2 Zn(II) ATP Probe (gift from Dr. Itaru Hamachi, Kyoto, Japan); Vybrant1 FAMCaspase-3
and -7 assay kit (V35118), Eosin-5-maleimide (E118), 1,2,3-dihydrorhodamine (D24806),
Hank’s balanced salt solution with Ca2+ and Mg2+ (HBSS++) (14025) or without Ca2+ and Mg2+
(HBSS—) (14175), YO-PRO1-1 iodide (λ ex/em 491/509) (Y3603), NuPAGE LDS Sample Buffer
(NP0007, Life Technologies, Carlsbad, CA, USA); IgG and protease-free BSA (Jackson Immu-
noResearch, West Grove, PA, USA); ATP (A2383-5g), L-glutathione, reduced (G4251),
Luperox1 TBH70X tert-butyl hydroperoxide solution (458139), Diphenyleneiodonium chloride
(DPI, D2926), sodium orthovanadate (S6508), MK-571 sodium salt hydrate (M7571), ovalbumin
(A5503, Sigma-Aldrich); ENLITEN1 ATP Assay System (FF2021), rATP (P1138, Promega,
Madison, WI, USA); NSC23788 (553502), glutathione monoethyl ester (353905), GlyH-101
(219671, EMDMillipore, Billerica, MA, USA); 8-bromo cAMP sodium salt (1140), calphostin C
(1626), indomethacin (1708), iso-PPADS (0683), KT5720 (1288), Phorbol 12-myristate 13-ace-
tate (PMA) (1201), PPADS (0625), Procaspase-activating compound (PAC) 1 (2581), suramin
hexasodium salt (1472), Z-DEVD-FMK (2166, R&D Systems, Minneapolis, MN, USA).
Preparation of Red Blood Cells (RBCs)
Blood was obtained from healthy adult volunteers in accordance with the guidelines of, and
approved by the Institutional Review Board of Beth Israel Deaconess Medical Center. Donors
from multiple diversities were recruited by local advertising and written, informed consent was
obtained from each volunteer in accordance with the Declaration of Helsinki. Approved study
staff were responsible for all blood collection, processing, and documentation of consent files.
Red blood cells were isolated as previously described [19]. For flow cytometry and microscopy
experiments, 20–80 μL RBCs were harvested by finger prick and collected into a microcentri-
fuge tube containing HBSS++ with 0.05% IgG-free BSA. RBCs were centrifuged (5,000 x g, RT,
1 min), and supernatant was removed by aspiration. This step was repeated 2 times.
Criteria for Sepsis and Septic Shock Patient Samples–For this study, "sepsis" was defined as
meeting systemic inflammatory response criteria in the setting of infection, whereas severe sep-
sis was defined as sepsis plus organ failure. These definitions are based on the American Col-
lege of Chest Physicians/Society of Critical Care Medicine Consensus Conference [20].
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ATP release measurement from RBC
RBCs (2% Hct in HBSS++, 0.05% BSA) were placed in 1.5 mL reaction tubes and mixed with
inhibitors or activators already placed in the tubes to minimize stimulation. Following incuba-
tion (RT x 10 min), RBCs were centrifuged (500 x g, RT, 2 min), the supernatant was discarded
and RBCs were resuspended in buffer using an electronic pipette with the appropriate inhibitor
or activator or buffer alone and again centrifuged (500 x g, RT, 2 min). Five replicate aliquots
were placed into black, flat-bottom, 96-well plates, and ATP concentration was measured as
described before [19].
Hemolysis
Remaining cell suspensions were centrifuged (5,000 x g, RT, 2 min) and 80 μL of supernatant
was measured at 415 nm using a VersaMax spectrophotometer (Molecular Devices, Sunnyvale,
CA, USA). Experiments were excluded from this study if RBC hemolysis exceeded 0.25%
Immunoblotting
RBCs were analyzed as previously described [21]. Nitrocellulose membranes were developed
with SuperSignal1West Pico or Femto Chemiluminescent Substrate [22] and imaged using
the LAS 4000 imaging system (Fujifilm).
Flow Cytometry
RBCs were analyzed using either FACScan or LSR II (BD Biosciences, San Jose, CA, USA). In
all experiments 100,000 events were recorded and analyzed using FlowJo software Version
9.3.3. For each figure, a representative histogram displaying the mean fluorescent intensity [23]
is shown, in addition to a cumulative graph for all experiments conducted.
Measurement of complement components
Complement deposition on human RBCs was measured by incubation (37°C, 30 min) of RBC
(0.5% Hct) with either mAb C4d, mAb C3d, or mAb IgG control (1:100) as described before
[24]
Measurement of ROS, activated caspase-3 and phosphorylated band 3/
AE1
RBC (1% Hct in HBSS++, without BSA) were incubated with 5μM dihydrorhodamine (DHR)
123 (37°C x 30 min). Activated caspase-3 was detected with Vybrant1 FAM Caspase-3 and -7
Assay Kit. Phosphorylated band 3 was determined using eosin-5-maleimide (EMA, 37°C x 30
min).
Fluorescence Recovery After Photobleaching
RBC lipid mobility was measured by incubating (RT x 30 min) RBC (10% Hct in HBSS++) with
DiO lipid dye (15 μg/mL) and washed prior to addition of antibodies or reagents. RBCs were
imaged using a 60x objective on an Olympus microscope and bleached with Vector Controller
Laser and analyzed as described before [19].
RBCMembrane Deformability
2D microchannel arrays were used as described in [25]. The cells were recorded using a 40 x
0.75 Ph2 Plan Fluorite objective on a TE300 Nikon-inverted microscope (Nikon Inc., Melville,
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NY, USA), using a Retiga EXi (QImaging, Surrey, Canada) CCD camera controlled by iVision
4.7 software (BioVision) at a rate of 10 frames/s. Movies were analyzed off-line frame by frame,
and RBCs that displayed unusual shapes, overlapped, or clustered were excluded from mea-
surement. For each experimental condition at least 50 RBCs were counted.
Statistical Analysis
All flow cytometry experiments were analyzed using FlowJo version 9.6.4 (TreeStar) or higher.
Statistical tests were performed using Prism version 4.0 (GraphPad). All error bars represent
the mean of 5 readings + S.D. unless noted otherwise.
Results
Ligation of GPA stimulates ROS production
DHR 123-loaded RBCs were incubated with tert-butyl hydroperoxide (t-BHP), a known ROS
promoter. t-BHP (10, 100 μM) increased intra-RBC ROS production in a concentration depen-
dent manner (S1 Fig), fromMFI = 35.7 in control RBCs to 49.6 and 1164, respectively. For in
vitro experiments, we elected to ligate GPA with monoclonal antibodies (mAb), which induce
profound changes in human RBCs during pathologies associated with naturally occurring anti-
GPA antibodies [9]. Ligation of GPA with mAb anti-GPA (Fig 1A, top left panel) increased
intra-RBC ROS production over control, fromMFI = 7.9 to 16.5, and pretreating RBCs with
the cell permeable ROS scavenger GSH-ME (1 mM) reduced GPA-mediated ROS increase
below basal levels (MFI = 6.18, top right panel), indicating that at basal conditions circulating
RBCs contain low but measurable levels of ROS. To confirm that ROS production was due to
the direct and specific engagement of GPA, we ligated RBC CR1, which we have shown
increases RBC membrane deformability [25] and triggers a robust ATP response [19]. Here,
Fig 1. GPA ligation on human RBCs stimulates ROS production via Rac 1 and NOX. (A) Ligation of GPA
promotes ROS production in RBCs; Cell permeable GSH-ME reduces ROS. RBCs preloaded with DHR 123
were treated with anti-GPA (mAb E4, 1 μg/mL) or IgM control mAb in the presence or absence of 1 mM
GSH-ME (RT x 10 min). Cells were washed twice and recorded by flow cytometry. Lower panels:RBCs
were incubated with either IgG or anti-CR1 under similar conditions (bottom right). (B) GPA-induced ROS
production dependent on NOX. RBCs preloaded with DHR 123 were treated with either control IgM or anti-
GPA (mAb E4) in the presence or absence of NOX inhibitor, DPI (10 μM, 37° x 60 min). RBCs were washed
twice and analyzed by flow cytometry. Right panel shows cumulative results of the same experiment. (C)
GPA-induced ROS production dependent on Rac 1. RBCs preloaded with DHR 123 were treated with either
control IgM or anti-GPA (mAb E4) in the presence or absence of Rac 1 inhibitor,NSC23766 (500 μM, 37° x
60 min). RBCs were then washed and analyzed by flow cytometry.
doi:10.1371/journal.pone.0141206.g001
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ligation of RBC CR1 did not promote any measurable increase in intra-RBC ROS production
(Fig 1A, lower right), suggesting that: a) GPA-mediated RBC ROS generation is not due to a
non-specific response of RBCs to engagement of membrane proteins by antibody, and b) the
increase in partially inhibited by the cell permeable ROS scavenger, GSH_ME (Fig 1A, lower
left panel). Recently, NADPH oxidase [26] was identified as a critical enzyme in RBC ROS pro-
duction, both in healthy and sickle RBCs [27]. We used DPI, a potent NOX inhibitor, to test if
GPA-mediated ROS production is dependent on NOX activity. Inhibition of NOX activity by
preincubation of RBCs with 10 μMDPI decreased the intracellular ROS concentrations in
GPA-ligated RBCs fromMFI = 35.4 to MFI = 19.5 (IgM control MFI = 12.2) (Fig 1B) suggest-
ing a significant role of NOX in GPA-mediated ROS production. In addition, the GTP-ase pro-
tein Rac1 was recently implicated as an activator of NOX in human RBCs[27], and therefore
critical to RBC ROS production. To test the involvement of Rac1 in GPA-mediated ROS pro-
duction we next treated RBCs with a cell permeable Rac1 inhibitor (NSC23766) prior to GPA
ligation, and observed a similar decrease in ROS levels, fromMFI = 26.3 to MFI = 14.8 (Fig
1C), suggesting that GPA ligation induces an increase in RBC ROS production that is mediated
by Rac1 and NOX.
GPA ligation induces caspase-3 activation through increased
intracellular ROS
In the past, others have shown a correlation between intracellular ROS accumulation and cas-
pase-3 activation [28]. We therefore asked if GPA-induced ROS production activated caspase-
3. RBCs pretreated with FLICA were incubated with either control IgM, anti-GPA (E4), or
10 μM PAC-1 (positive control) for 15 min at RT. Using flow cytometry, we observed a 4.3x
increase in caspase-3 activation in GPA-ligated RBCs (Fig 2A) compared to IgM control,
(MFI = 28.3 vs. MFI = 6.6), similar to our positive control (MFI = 23.1). Incubation of RBCs
with known ROS promoter t-BHP generated a dose dependent increase in caspase-3 activation
from basal MFI levels of 3.52 to 39.6 (1 mM) and 99.4 MFI (3 mM, Fig 2B, left). Similar to our
previous results (Fig 1A), incubation of RBCs with anti-CR1 did not trigger activation of
procaspase-3 (Fig 2C), also suggesting that GPA-dependent activation of caspase-3 is not a
non-specific response of RBCs to GPA ligation. We next investigated the pattern of caspase-3
activation induced by GPA ligation by fluorescence microscopy (Fig 2D). Interestingly, the dis-
tribution of activated caspase-3 showed a punctuated pattern near the membrane following
GPA ligation (top panels), and a uniform cytoplasmic staining following t-BHP-dependent
activation (bottom panels). Taken together, our data suggest that ligation of GPA triggers an
increased intracellular production of ROS that is responsible for activation of procaspase-3.
GPA-mediated ATP release depends critically on intracellular ROS
To determine if a pore large enough to allow ATP (375 Da) release opens following GPA liga-
tion, we incubated RBCs with YO-PRO1-1 iodide, a cell impermeant nucleic acid stain that
has been used to quantify gap junction channels, a family of pores that allow passage of small
molecules such as ATP [29]. Ligation of GPA using the R10 epitope (Fig 3A, bottom panel)
induced an increase in RBC-associated fluorescence from 58 to 78 AU when compared to con-
trol Ab (top panel). To ensure that this increase was not the result of antibody-induced cell
aggregation, we measured the size distribution of RBCs before and after GPA ligation (Fig 3A,
right panel). Having determined that a membrane pore was opening following GPA ligation,
we investigated whether ATP was simultaneously released. RBCs incubated with anti-GPA
(R10 and E4) significantly increased ATP concentration in the supernatant from 4.6 ± 0.4 nM
to 10.8 ± 0.8 nM (R10) and 10.0 ± 1.6 nM (E4) (p< 0.008) (Fig 3B). We next incubated RBCs
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with a fluorescent ATP probe 2–2 Zn(II), which binds to the extracellular side of the plasma
membrane and fluoresces upon interaction with ATP as it is released. [19] GPA ligated RBCs
showed a significant increase in ATP release compared to control, fromMFI = 39.6 to
MFI = 1282 (unstained MFI = 5.3) (Fig 3C, left panel). This dye promotes cell aggregation due
to its lipophilic nature [19], however this did not prevent observing fluorescent ATP levels for
each cell. A similar increase in fluorescence intensity was observed using wide field fluores-
cence 3-D acquisition followed by deconvolution (right panels). RBCs incubated with t-BHP
(100 μM and 1 mM) also released increased amounts of ATP, from 5.4 ± 1.2 nM to 7.4 ± 1.1
nM and 10.0 ± 2.1 nM, respectively (p< 0.01) (Fig 3D). Pretreatment of RBCs using the cell-
permeable glutathione monoethyl ester (GSH-ME, 1 mM) significantly decreased the amount
of ATP following GPA ligation, from 10.8 ± 0.6 nM to 8.2 ± 1.0 nM (p< 0.008) (Fig 3E). How-
ever, pretreatment under similar conditions with cell impermeable glutathione (GSH) had no
effect (anti-GPA = 13.1 ± 2.2 nM, anti-GPA + GSH = 13.4 ± 1.2 nM, p = 1) (Fig 3F), suggesting
that the extracellular ROS-based autocrine effect on RBCs was not required for the GPA-medi-
ated ATP release. Next, we asked if caspase-3 played a role in ATP release following GPA-liga-
tion. Incubation of RBCs with caspase-3 activator PAC 1 (1 and 10 μM) triggered a significant
increase in ATP release, from 5.5 ± 0.5 nM to 6.9 ± 0.5 nM and 11.4 ± 0.2 nM, respectively
Fig 2. GPA ligation induces ROS dependent caspase-3 activation. (A) GPA ligation activates caspase-3.
RBCs preloaded with FLICA (1X) were incubatedwith IgM control, PAC-1 (10 μM), or anti-GPA (mAb E4).
Cells were washed twice and analyzed by flow cytometry. (B) ROS induces caspase-3 activation in RBCs.
RBCs pretreated with FLICA were incubated with buffer, 1 mM or 3 mM t-BHP. RBCs were washed and
analyzed by flow cytometry. (C) Cumulative data including RBCs incubated with IgG anti-CR1 as a negative
control. (D) Microscopy images illustrating caspase-3 activation in human RBCs. RBCs pretreated with
FLICA were incubated with anti-GPAmAb (E4, 2 μg/mL, top panels), buffer, or 10 μM t-BHP (bottom panels),
followed by Alexa 594 fluorescent secondary antibody. RBCs were washed and loaded onto a microscope
slide. Images of GPA ligation (left) and caspase-3 activation (center) were taken using an OlympusBX62
fluorescence microscope and further analyzed using 3D deconvolution on Slidebook Pro. The images were
then merged together (right). The bottom images were taken using fluorescence microscopy.
doi:10.1371/journal.pone.0141206.g002
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(p< 0.02) (Fig 3G). However, pre-incubation of RBCs with a caspase-3 inhibitor, FAM-
DEVD-X, prior to GPA ligation did not significantly alter ATP release (p = 0.2) (Fig 3H). Our
data suggest that GPA ligation-induced ATP release is dependent on intracellular but not
Fig 3. GPA-ligation opens a channel, promotes ATP release through ROS. (A) GPA ligation
permeabilizes RBCs for YO-PRO1-1 iodide (YO-PRO). Cells were incubated with YO-PRO and analyzed by
kinetics using flow cytometry. Baseline values were acquired followed by addition of IgG control Ab and then
either IgG control (top) or anti-GPAmAb (R10) (bottom). Arrows indicate time point of antibody addition. The
size distribution of RBCs is also shown (right panel). (B) Ligation of GPAmAbs induces ATP release. RBCs
were incubated with IgG, anti-GPAmAb (R10 and E4) and ATP release was measured. (C) GPA-mediated
ATP release measured by ATP-specific fluorescent probe, 2-2Zn(II). RBCs were pretreated with 1 μM 2-2Zn
(II) prior to incubation with either control IgM or anti-GPAmAb. ATP release was measured by flow
cytometry. RBCs were imaged by wide-field fluorescence microscopy followed by deconvolution. (D) ROS
generation in RBCs induces ATP release. RBCs treated with buffer (black bar) or two concentrations of t-
BHP. (E) Cell permeable GSH-ME reduces GPA-mediated ATP release. RBCs were incubated with buffer
(black bars) or 1 mMGSH-ME. RBCs were then treated with anti-GPA mAb (R10) or IgG control mAb, and
ATPmeasurements were acquired. (F) Extracellular ROS does not affect GPA-mediated ATP release. RBCs
were incubated with buffer or 1 mM non-cell permeable glutathione (GSH) and then treated with anti-GPA
mAb (R10) or IgG control mAb. (G) Caspase-3 activator PAC 1 induces ATP release in RBC. RBCs were pre-
incubated with 1% DMSO (control) or two concentrations (1 and 10 μM) of PAC 1 before ATP measurements
were determined. (H) Inhibition of caspase-3 does not reduce GPA-mediated ATP release. RBCs were pre-
incubated (RT x 10 min) with 0.1% DMSO (control) or the cell-permeable caspase-3 inhibitor Z-DEVD-FMK
(10 μM). RBCs were treated with anti-GPAmAb (R10) or IgG control mAb (both 5 μg/mL).
doi:10.1371/journal.pone.0141206.g003
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extracellular ROS levels, and although GPA-mediated ROS production activates caspase-3, this
signaling may not be directly linked to GPA and ROS-induced ATP release.
Several pores and channels have been described to be functionally associated with ATP
release in RBCs such as pannexins, MRPs, and CFTR [30–32]. In particular, CFTR expression
and its involvement with ATP release was previously shown in murine RBCs [31]. Despite con-
firming the presence of CFTR on human RBCs by Western blot (S2 Fig), we were unable to
confirm its role in GPA-mediated ATP release using the specific inhibitor GlyH-101. Similarly,
MRP channels and purinergic receptors were not found to be independent conductors for ATP
released from RBCs secondary to GPA ligation (S2 Fig).
Intracellular ROS production decreases membrane deformability
We have previously reported that during chronic inflammations such as in SLE and trauma,
RBCs undergo alteration in the phosphorylation levels of β-spectrin and band 3 [5,6]. Impor-
tantly, band 3 phosphorylation was recently reported to depend critically on protein kinase
p72 Syk, an enzyme that is activated by increased intra-RBC ROS [33]. We next investigated
the effect of RBC GPA ligation on tyrosine phosphorylation of band 3, and its dependence on
ROS. We used eosin-5-maleimide (EMA) as an indirect marker for band 3 phosphorylation.
The efficiency of EMA binding to lysine 430 on the extracellular loop of band 3 was shown to
parallel the levels of band 3 tyrosine phosphorylation, although the details of the binding are
currently poorly understood [34]. Our data show that anti-GPA mAb (E4) induced band 3
phosphorylation (E4 MFI = 25.5, control MFI = 14.6) (Fig 4A, top left panel), an increase that
was significantly reduced when RBCs were pretreated with GSH-ME (E4 MFI = 14.9). Also,
incubation of RBCs with 100 μM t-BHP triggered an increase in band 3 phosphorylation from
MFI = 14.6 to 17.7 (top right panel). In both experiments, band 3 phosphorylation was
reduced following pretreatment with GSH-ME (100 μM t-BHP MFI = 6.4), suggesting that the
baseline phosphorylation levels of band 3 depend partially on ROS. This was further confirmed
by Western blotting (bottom right panel) using anti-phosphotyrosine, pY20 (Biosource) as a
developing antibody. As a positive control, RBCs were incubated with sodium ortho-vanadate.
We next asked if the effect of GPA ligation on membrane deformability is a result of excessive
ROS generation, and if ROS scavengers can prevent it. We used 2-D microchannels to assess
RBC deformability, measured as the time required for RBCs to pass through a capillary-like
array (Fig 4B, top panel). Ligation of GPA increased the average time required for RBCs to
pass through the capillary-like channel, from 2.7 ± 0.2 s to 3.7 ± 0.5 s (p< 0.01). However,
GPA-ligated RBCs in the presence of GSH-ME required less time to deform and move through
the channels (2.6 ± 0.2 s, p< 0.001), suggesting that intracellular ROS is in part responsible for
the GPA-mediated decrease in membrane deformability (Fig 4B, bottom panel).
GPA-mediated ROS production inhibits lipid mobility
We next investigated the role of GPA-mediated ROS production on plasma membrane lipid
mobility using fluorescence recovery after photobleaching (FRAP). Fig 4C shows serial images
of a representative RBC during a FRAP experiment, while a corresponding recovery rate of the
membrane at the specified region is shown in Fig 4D. GPA-ligated RBCs resulted in a signifi-
cant reduction in the mobile fraction from 87.5 ± 3.7% in control IgM-treated RBCs down to
77.4 ± 3.4% (p< 0.0001) (Fig 4E). Our results also show that pretreatment with GSH-ME
restored the GPA-mediated loss in lipid mobility, with a mobile fraction of 91.0 ± 4.0% com-
pared to 77.4 ± 3.4% (p< 0.0001).
Ligation of GPA Decreases RBC Deformability
PLOS ONE | DOI:10.1371/journal.pone.0141206 January 19, 2016 9 / 16
Complement-altered RBCs from septic patients partially recapitulate the
functional phenotype of GPA-ligated RBCs
RBCs from 27 sepsis patients and 22 controls were analyzed for complement deposition, ROS
production, band 3 phosphorylation, ATP release, membrane deformability, and lipid mobil-
ity. Not all patient samples were investigated for all functional parameters. The results are pre-
sented as ratios between the measured value of septic over control RBCs. Fig 5A shows that in
the case of C4d fragments (right panel), deposition of RBCs from septic patients was more pro-
nounced in severe septic and septic shock when compared to controls, whereas C3d fragments
in (left panel) septic shock patients had levels not different than uninfected controls. RBC band
3 phosphorylation was not uniformly increased in sepsis patients; only a few patients displayed
increased levels of band 3 phosphorylation, without a clear correlation between the RBC
Fig 4. RBC ROS production induces Band 3 phosphorylation, decreasing membrane deformability
and lipid mobility. (A) GPAmediated ROS production increases band 3 phosphorylation. RBCs pretreated
with buffer or 1 mMGSH-ME in the presence of EMA were then incubated with anti-GPAmAb (E4, 1 μg/mL
or R10, 5 μg/mL), IgG control mAb (5 μg/mL, all top left panel), or t-BHP (100 and 200 μM, top right panel).
RBCs were washed twice and analyzed by flow cytometry. Bottom right panel: Western blot of RBCs treated
with IgG control, anti-GPA, or Na3VO4. Samples were probed with anti-phosphotyrosine. (B) GPA-mediated
ROS production decreases membrane deformability. RBCs were incubated with either control or anti-GPA
(E4) Ab (1ug/ml) in the presence or absence of GSH-ME (1 mM). Sequential images (3 frames/sec) were
recorded of each cell’s passage through the channel. (C) Serial snapshots of a RBC during a standard FRAP
experiment, with a 1 x 1 μm targeted area for bleaching. (D) Standard FRAP recovery curve. Black line: the
original recovery curve measured in the bleached area, red line: the photobleaching rate measured on the
same cell away from the bleached area, blue curve: the final recovery rate calculated using Slidebook. (E)
Treatment of RBC with GPA decreases lipid recovery rate, which is partially restored by GSH-ME. RBCs
were pretreated with 1μMGSH-ME for (RT x 5 min) and then incubated with control or anti-GPA antibody
(1 μg/ml, RT x 10 min).
doi:10.1371/journal.pone.0141206.g004
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complement levels and the intensity of band 3 staining (Fig 5B). Conversely, intra-RBC ROS con-
centrations were increased in all septic samples studied (Fig 5C). When measuring the ATP con-
centration in the supernatant, we observed a gradual decrease in the amount of ATP that
correlated inversely with the severity of sepsis (Fig 5D). Consistent with our in vitro FRAP data
RBC lipid mobility of 4 patients with septic shock (Fig 5E) was significantly decreased (Mfcontrol =
87.5%, Mf sepsis = 80.6%, p< 0.0008), when compared to matched controls. Consistent with previ-
ous reports [35–37], RBCs from septic shock patients also showed a significant decrease in mem-
brane deformability (Fig 5F), as measured by 2-D microchannel arrays (tcontrol = 3.2 seconds,
tsepsis = 4 seconds, p< 0.0001). Moreover, RBCs isolated from septic patients treated with 1 mM
GSH-ME for 15 minutes prior to functional analyses partially restored both membrane deform-
ability (from 4 to 3.2 seconds) as well as lipid mobility (fromMfcontrol = 80.6% to Mfsepsis =
89.6%), suggesting that the beneficial microcirculatory effects of antioxidant therapy reported in
sepsis [38] could also be attributed to its effect on the mechanical properties of circulating RBCs.
Discussion
In this study, we investigated the deleterious effects of RBC ROS production promoted by GPA
ligation using both in vitro and ex vivo approaches. Our data demonstrate that ligation of GPA
Fig 5. RBCs from Septic Patients partially recapitulates functional phenotype of GPA-ligated RBCs.
(A) RBCs from septic patients show increased presence of C4d fragments, but not C3d. RBCs isolated from
patient samples were incubated with anti-C3d or anti-C4d and analyzed by flow cytometry. (B) RBCs from
septic patients do not show uniform increase in band 3 phosphorylation. RBCs from septic and control
patients were incubated with EMA, washed twice, and band 3 phosphorylation was measured by flow
cytometry. (C) ROS levels increased in septic RBCs. RBCs were incubated with DHR 123, washed twice,
and measured for intracellular ROS by flow cytometry. (D) RBCs from septic patients release less ATP than
control RBCs. RBCs from septic and control patients were isolated and ATP concentration was measured as
described in Methods. (E) Sepsis-induced decrease in RBC lipid mobility depends on ROS. RBCs from
control and septic patients were incubated with DiO lipid dye in the presence or absence of GSH-ME (1 mM)
prior to running FRAP. (F) Sepsis-dependent loss of RBCmembrane deformability depends on ROS. RBCs
from control and septic patients were washed and loaded into a 2D microfluidic device in the presence or
absence of GSH-ME (1 mM, RT x 15 min). Sequential images (3 frames/sec) were recorded of each cell’s
passage through the channel.
doi:10.1371/journal.pone.0141206.g005
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by antibody initiates a NOX-dependent increase in ROS production. In turn, elevated intracel-
lular ROS triggers multiple signaling cascades culminating in loss of RBC mechanical functions
and ATP release, both of which could partially explain the flow alterations described in sepsis.
Others have shown that Rac GTP-ases and PKC contribute to greater oxidative stress in sickle
cell RBCs by increasing erythrocyte NOX activity [27]. Our data show a similar signaling path-
way whereby GPA ligation activates Rac 1, increasing NOX activity, and generating ROS. How-
ever, the GPA-mediated ROS production seems not to fall under the classical NOX activation
pathway involving activation of PKC and phospholipase A2 [39]. Both steps require Ca++, yet
engagement of GPA by antibody does not promote a measurable Ca++ influx. Furthermore,
inhibition of PKC with calphostin C prior to GPA ligation does not prevent ROS production,
suggesting that additional mechanisms involved in activation of NOX play a role in GPA-
mediated ATP release.
Human RBCs contain large amounts of procaspase-3, considered a leftover erythropoiesis
protein [40]. In nucleated cells, reports show a correlation between increased intracellular ROS
and programmed cell death by direct activation of caspase-3 [28]. Our results show that GPA
activates caspase-3, but in a different manner than t-BHP; whereas t-BHP generated cell-wide
activation, resulting in uniform staining, GPA-ligation activated caspase-3 in a punctuated,
well-defined pattern. Localized, transient, functional domains have been described in RBCs as
a result of specific signaling pathway responses [41]. It is conceivable a similar mechanism is
responsible for limited activation of caspase-3, although they did not co-localize with GPA
molecules.
Recently, a novel role for ATP in RBC mechanical properties has been uncovered [42–47].
We here have showed using fluorescence microscopy and flow cytometry using a novel ATP
probe [19] that GPA ligation by antibody induces a robust increase in ATP released by RBCs.
This increase was significantly reduced in the presence of additional antioxidants such as the
cell-permeable GSH-ME. While we observed a significant ATP release in RBCs treated with
PAC-1, further experiments did not support our hypothesis that this release was causally linked
to GPA ligation (Fig 2G and 2H). It is therefore likely that increased ROS levels induce multi-
ple responses from RBCs including caspase-3 activation and ATP release.
We previously reported an inability to identify pannexin-1 in human RBCs using flow
cytometry or immuno-blotting methods [19]. However, MRP1 and MRP4 were previously
involved in ATP release, and both were identified in human RBCs by mass spectrometry [48].
Using the specific inhibitor MK-571, we showed RBC MRP1 is involved in CR1-mediated ATP
release [19]. Moreover, previous reports show mice with CF having increased ATP concentra-
tions in blood [31], while others have reported the importance of purinergic receptors as regu-
lators of ATP release in osteoclasts [49]. In spite of promising data, we could not confirm the
role of any of these channels in mediating ATP release following GPA ligation.
Our data obtained using RBCs isolated from septic patients paradoxically showed an oppo-
site trend from our in vitro results. Even though there is an increased activity of plasma ecto-
nucleases in sepsis that directly lowers plasma ATP concentrations due to bacterial presence
and generalized inflammation [50,51], our experiments using isolated and purified RBCs sug-
gest that another mechanism is responsible for diminished RBC ATP release in sepsis.
Increased concentrations of extracellular ADP reversibly inhibit RBC ATP release by acting on
P2Y13 receptors on RBC membranes through a c-AMP dependent mechanism [52]. During
septic episodes, the blood concentration of ADP increases 6–8 times over control (from 1.2 to
8.4 μM/L), decreasing to near normal values 72 hours post-sepsis [53]. Patients in our study
were enrolled within a 24-hour window post admission, providing a possible explanation for
the observed, ex vivo low ATP release by complement-altered RBCs isolated from septic
patients.
Ligation of GPA Decreases RBC Deformability
PLOS ONE | DOI:10.1371/journal.pone.0141206 January 19, 2016 12 / 16
Our results regarding C3d levels on circulating RBCs from sepsis patients were indistin-
guishable from control samples. In humans, C3 fragments present on RBC membranes have
been shown to decrease RBC membrane deformability [7] and significantly shorten the half-
life of circulating RBCs compared to RBC-bound C4 fragments [54]. It is possible that, at the
onset of the disease, complement is not fully activated, whereas after time, the less deformable
RBCs are trapped in the spleen and liver or removed from circulation. This mechanism could
provide an explanation as to why C4 fragments are present on RBC membranes from sepsis
patients, while the C3b-RBCs are missing.
Septic patients display a wide array of microcirculatory flow disturbances [55–58]. Consis-
tent with our in vitro data, our ex vivo functional results indicate that RBCs from septic patients
show a significant decrease in RBC membrane deformability and lipid mobility. These results
indicate that the marked changes in membrane deformability due to GPA ligation either by
complement fragments C3b, C4b, or antibodies are the result of GPA-specific signaling cas-
cades rather than passive, antibody-driven cross-linking of membrane proteins.
In summary, our findings regarding GPA engagement by complement fragments or autoan-
tibodies reveal a novel and detrimental role of circulating RBCs during inflammatory condi-
tions. Overwhelming intracellular ROS concentrations ultimately impair critical RBC
mechanical capabilities, thus disrupting their movement and interactions within the microvas-
culature. The data point to complement-altered RBCs as possible effector cells, actively influ-
encing nearby cells through release of bioactive molecules such as ROS and ATP.
Supporting Information
S1 Fig. t-BHP produces ROS in RBCs. Treatment of RBCs with tert-butyl hydroperoxide (t-
BHP) induces ROS. RBCs were incubated with 10 or 100 μM t-BHP in the presence of 5 μM
DHR 123. Cells were washed twice and recorded by flow cytometry. The left panel is a repre-
sentative experiment and the right panel is the cumulative data taken from all experiments.
(JPG)
S2 Fig. MRP and CFTR channels not solely responsible for GPA-mediated ATP release. (A)
Detection of CFTR by immunoblotting. Ghosted RBC membranes (non-boiled) were resus-
pended in 1x LDS Sample Buffer, separated using SDS NuPAGE, and transferred onto nitrocel-
lulose membrane. Mouse lung lysate served as positive control (lane 3); lane 2 was left empty.
(B) CFTR Inhibitor raises baseline ATP levels in RBC. RBCs were pre-incubated with DMSO
(control) or two concentrations of GlyH-101. ATP concentration was determined as described
in Experimental Procedures. (C) Inhibition of CFTR does not reduce GPA-mediated ATP
release. RBCs were pre-incubated with 0.1% DMSO (control) or 1 μMGlyH-101. RBCs were
then washed twice with buffer containing1 μMGlyH-101 and ligated with anti-GPA mAb
(R10) or IgG control mAb (5 μg/mL). Extracellular ATP concentration was determined as
described in Experimental Procedures. (D) Indomethacin does not inhibit GPA-mediated ATP
release. RBCs were pre-incubated with 0.1% DMSO (control) or 10 μM indomethacin. RBCs
were then ligated with either control IgG or anti-GPA mAb. ATP concentration was deter-
mined as described in Experimental Procedures. (E) MRP channels are not responsible for
GPA mediated ATP release. RBCs were pre-incubated with buffer or 10 μMMK-571, a known
specific of MRPs. RBCs were then processed as outlined in methods with the antibodies given
during the last resuspension step. ATP concentration was determined as described in Experi-
mental Procedures. (F) Inhibition of P2 receptors does not reduce GPA-mediated ATP release.
RBCs were pre-incubated (RT x 10 min) with buffer or either 10 μM PPADS (left graph), iso-
PPADS (middle graph) or suramin (right graph). RBCs were then processed as outlined in
methods with the antibodies given during the last resuspension step. ATP concentration was
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determined as described in Experimental Procedures.
(JPG)
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